Gemcitabine (dFdCyd) shows broad antitumor activity in solid tumors in chemotherapeutic regimens or when combined with ionizing radiation (radiosensitization). While it is known that mismatches in DNA are necessary for dFdCyd radiosensitization, the critical event resulting in radiosensitization has not been identified. Here we hypothesized that late DNA damage (≥24 h after drug washout/irradiation) is a causal event in radiosensitization by dFdCyd, and that homologous recombination repair (HRR) is required for this late DNA damage. Using γ-H2AX as a measurement of DNA damage in MCF-7 breast cancer cells, we demonstrate that 10 or 80 nM dFdCyd alone produced significantly more late DNA damage compared to that observed within 4 h after treatment. The combination of dFdCyd treatment followed by irradiation did not produce a consistent increase in DNA damage in the first 4 h after treatment, however, there was a synergistic increase 24–48 h later relative to treatment with dFdCyd or radiation alone. RNAi suppression of the essential HRR protein, XRCC3, significantly decreased both radiosensitization and late DNA damage. Furthermore, inhibition of HRR with the Rad51 inhibitor B02 prevented radiosensitization when added after, but not during, treatment with dFdCyd and radiation. To our knowledge, this is the first published study to show that radiosensitization with dFdCyd results from a synergistic increase in DNA damage at 24–48 h after drug and radiation treatment, and that this damage and radiosensitization require HRR. These results suggest that tumors that overexpress HRR will be more vulnerable to chemoradiotherapy, and treatments that increase HRR and/or mismatches in DNA will enhance dFdCyd radiosensitization.
Skip Nav Destination
Close
Article navigation
1 November 2016
Research Article|
October 14 2016
Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine
Michael M. Im
;
Michael M. Im
Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Search for other works by this author on:
Sheryl A. Flanagan
;
Sheryl A. Flanagan
Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Search for other works by this author on:
Jeffrey J. Ackroyd
;
Jeffrey J. Ackroyd
Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Search for other works by this author on:
Brendan Knapp
;
Brendan Knapp
Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Search for other works by this author on:
Aaron Kramer
;
Aaron Kramer
Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Search for other works by this author on:
Donna S. Shewach
Donna S. Shewach
1
Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, Michigan 48109
1Address for correspondence: 4742 Medical Science II, University of Michigan Medical School, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-5633; email: dshewach@umich.edu.
Search for other works by this author on:
Radiat Res (2016) 186 (5): 466–477.
Citation
Michael M. Im, Sheryl A. Flanagan, Jeffrey J. Ackroyd, Brendan Knapp, Aaron Kramer, Donna S. Shewach; Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine. Radiat Res 1 November 2016; 186 (5): 466–477. doi: https://doi.org/10.1667/RR14443.1
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner